M. Uysal Et Al. , "Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab," BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.4, pp.409-412, 2014
Uysal, M. Et Al. 2014. Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab. BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.4 , 409-412.
Uysal, M., Bozcuk, H., Göksu, S. S., Tatlı, A. M., Arslan, D., Gunduz, S., ... COŞKUN, H. Ş.(2014). Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab. BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.4, 409-412.
Uysal, Mukremin Et Al. "Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab," BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.4, 409-412, 2014
Uysal, Mukremin Et Al. "Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab." BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.4, pp.409-412, 2014
Uysal, M. Et Al. (2014) . "Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab." BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.4, pp.409-412.
@article{article, author={Mukremin Uysal Et Al. }, title={Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab}, journal={BIOMEDICINE & PHARMACOTHERAPY}, year=2014, pages={409-412} }